Evaluation of the relationship between the occurrence of anemia and the impact of fatigue on the quality of life of patients undergoing chemotherapy

Authors

  • Jorge Freitas Instituto Português de Oncologia do Porto Francisco Gentil (Serviço de Oncologia Médica Piso 3), Porto
  • AP Figueiredo Instituto Português de Oncologia do Porto Francisco Gentil (Serviço de Oncologia Médica Piso 3), Porto
  • M Santos Instituto Português de Oncologia do Porto Francisco Gentil (Serviço de Oncologia Médica Piso 3), Porto
  • E Valério Instituto Português de Oncologia do Porto Francisco Gentil (Clínica da Mama), Porto
  • MA Gomes Instituto Português de Oncologia do Porto Francisco Gentil (Clínica da Mama), Porto
  • C Sousa Clínica de Santo António (Hospital de Dia de Oncologia)
  • D Reis Clínica de Santo António (Hospital de Dia de Oncologia)
  • JM Silva Clínica de Santo António (Hospital de Dia de Oncologia)
  • Pinheiro M Instituto Português de Oncologia do Porto Francisco Gentil (Serviço de Oncologia Médica Piso 4), Porto
  • D Ramada Instituto Português de Oncologia do Porto Francisco Gentil (Serviço de Oncologia Médica Piso 4), Porto
  • A Pereira Instituto Português de Oncologia do Porto Francisco Gentil (Hospital de Dia), Porto
  • A Monteiro Instituto Português de Oncologia do Porto Francisco Gentil (Hospital de Dia), Porto
  • E Costa Hospital Pedro Hispano (Hospital de Dia)
  • A Ribeiro Hospital Pedro Hispano (Hospital de Dia)
  • C Coelho Hospital Pedro Hispano (Hospital de Dia)
  • V Teixeira Hospital Garcia de Orta (Serviço de Hemato-Oncologia)
  • E Alves Hospital de Santa Maria (Unidade de Pneumologia)
  • I Mendes Hospital de São Bernardo (Hospital Dia Oncologia)
  • M Bicho Hospital de Faro (Hospital de dia de Oncologia), Faro

DOI:

https://doi.org/10.31877/on.2010.15.01

Keywords:

Anemia, cancer, erythropoietin, quality of life, erythropoiesis-stimulating agents

Abstract

The increase of fatigue in cancer patients has been correlated with the development of chemotherapy-induced anaemia. There is a lack of information concerning the proportion of Portuguese cancer patients under chemotherapy that develop anaemia and concerning its management. This study aims to evaluate the impact of chemotherapy-induced anaemia and treatment in the quality of life of Portuguese cancer patients. Secondarily, we intend to characterize anaemia treatment options in those patients.

Downloads

Download data is not yet available.

References

Sabbatini, P., 2000. The relathionship between anemia and quality of life in cancer patients. The Oncologist 5, Suppl 2, 19-23.

Groopman, J.E., Itri, L.M., 1999. Chemotherapy-induced anemia in adults: Incidence and treatment. J Natl Cancer Inst 91, 1616-1634.

Wagner, L.I., Cella, D., 2004. Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer 91, 822– 828.

Luciani, A., Jacobsen, P.B., Extermann, M., et al, 2008. Fatigue and Functional dependence in older cancer patients. Am J Clin Oncol 31,

–430.

Curt, G.A., 2000. The impact of fatigue on patients with cancer: overview of FATIGUE 1 and 2. The Oncologist 5, Suppl 2, 9-12.

Yeh, C.H., Chiang, Y.C., Lin, L., et al, 2008. Clinical factors associated with fatigue over time in paediatric oncology patients receiving chemotherapy. Br J Cancer 8, 99(1), 23-9.

Portenoy, R.K., Itri, L.M., 1999. Cancer-related fatigue: Guidelines for evaluation and management. Oncologist 4, 1-10.

Wang, X.S., Giralt, S.A., Mendoza, T.R., et al, 2002. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin’s lymphoma. J Clin Oncol 20, 1319–1328.

Curt, G.A., Breitbart, W., Cella, D., et al, 2000. Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. Oncologist 5, 353-360.

Hamilton, H., Blum, D., Cella, D., et al, 2005. Communication regarding chemotherapy-induced anemia and related fatigue: Recommendations from an observational linguistic study. J Clin Oncol 23, Suppl 16, 740.

Cella, D., 2006. Quality of life and clinical decisions in chemotherapy-induced anemia. Oncology 20(8), 25–28.

Yellen, S.B., Cella, D.F., Webster, K., et al, 1997. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13, 63–74.

FACIT – Functional Assessment of Chronic Illness Therapy (Access on 10th October 2008: http://www.facit.org).

Mock, V., 2004. Evidence-based treatment for cancer-related fatigue. J Natl Cancer Inst Monogr 32,112–8.

National Comprehensive Cancer Network (NCCN). Practice Guidelines in Oncology-v.1.2002: Cancer and Treatment- Related Anemia.

Demetri, G.D., 2001. Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy. Br J Cancer 84, Suppl 1, 17–23.

Cella, D., 1998. Factors influencing quality of life in cancer patients: anemia and fatigue. Semin Oncol 25, 43-46.

Littlewood, T.J., 2002. Management options for cancer therapy-related anaemia. Drug Safety 25(7), 525-35.

Hurter, B., Bush, N.J., 2007. Cancer-related anemia: clinical review and management update. Clin J Oncol Nurs 11(3), 349-59.

Gillespie, T.W., 2005. Implementation of the NCCN practice guidelines: anemia and neutropenia. Adv Stud Nurs 3(9), 300-9.

Aapro, M.S., Link, H., 2008. September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents. Oncologist 13, Suppl 3, 33-6.

Estrin, J.T., Schocket, L., Kregenow, R., et al, 1999. A retrospective review of blood transfusions in cancer patients with anemia. The Oncologist 4, 318-324.

Smith, R.E., Tchekmedyian, S., 2002. Practitioners’ Practical model for managing cancer-related anemia. Oncology 16, Suppl 10, 55-63.

Khorana, A.A., Francis, C.W., Blumberg, N., et al, 2008. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med 168(21), 2377-2381.

Resumo das Características do Medicamento, Darbepoetina alfa, 2010.

Nogueira, F., Calais, F., Leal da Silva, J., et al, 2007. STARS – Surveillance on the Treatment of Anaemia: a Retrospective Survey. 14th European Cancer Conference, 23-27 November 2007, Barcelona.

Aapro, M., 2009. An Update on twenty years of anemia management with erythropoiesis-stimulating agents in nephrology and oncology/hematology. The Oncologist 14, Suppl 1, 1–5.

Ludwig, H., Barrett-Lee, P., Birgegard, G., et al, 2004. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 40, 2293-2306.

Ludwig, H., Fritz, E., 1998. Anemia in cancer patients. Semin Oncol 25: 2-6.

Downloads

Published

2010-11-16

How to Cite

1.
Freitas J, Figueiredo A, Santos M, Valério E, Gomes M, Sousa C, Reis D, Silva J, Pinheiro M, Ramada D, Pereira A, Monteiro A, Costa E, Ribeiro A, Coelho C, Teixeira V, Alves E, Mendes I, Bicho M. Evaluation of the relationship between the occurrence of anemia and the impact of fatigue on the quality of life of patients undergoing chemotherapy. Onco.News [Internet]. 2010 Nov. 16 [cited 2024 Nov. 23];(15):7-12. Available from: https://onco.news/index.php/journal/article/view/215

Issue

No. 15 (2010): Onco.News Journal

Section

Original Articles

License

Copyright (c) 2023 Jorge Freitas, AP Figueiredo , M Santos , E Valério , MA Gomes , C Sousa , D Reis , JM Silva , Pinheiro M, D Ramada , A Pereira , A Monteiro , E Costa , A Ribeiro , C Coelho , V Teixeira , E Alves , I Mendes , M Bicho

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.